Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma

Fig. 3

Low expression of BTG1 in EC was significantly correlated with OS shortening. a qRT-PCR detects the expression of BTG1 in EC samples and normal tissue samples. b Expression of BTG1 in EC based on invasion depth. c Expression of BTG1 in EC based on FIGO stage. d Effect of BTG1 expression level on EC patient survival. *P < 0.05,**P < 0.01 and ***P < 0.001

Back to article page